Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges

Histology and Histopathology

Volumn 28, Issue 9, 2013, Pages 1109-1116

  Lin, Ching Shwun ^a   Xin, Zhong Cheng ^b   Dai, Jican ^c   Lue, Tom F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cell therapy; Differentiation; Engraftment; Mesenchymal stem cell markers; Tracking labels

Indexed keywords

BIOLOGICAL MARKER; CD34 ANTIGEN; CD70 ANTIGEN; CD70 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; COLORING AGENT; ENG PROTEIN, HUMAN; GREEN FLUORESCENT PROTEIN; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN; STRO 1 ANTIGEN, HUMAN; STRO-1 ANTIGEN, HUMAN; THY 1 ANTIGEN;

ANIMAL; CARTILAGE CELL; CELL DIFFERENTIATION; CELL MEMBRANE; CELL NUCLEUS; CHEMISTRY; CYTOLOGY; FLUORESCENCE MICROSCOPY; GENETIC MARKER; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; OSTEOCYTE; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD70; ANTIGENS, SURFACE; ANTIGENS, THY-1; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL MEMBRANE; CELL NUCLEUS; CHONDROCYTES; COLORING AGENTS; GENETIC MARKERS; GREEN FLUORESCENT PROTEINS; HUMANS; MESENCHYMAL STROMAL CELLS; MICROSCOPY, FLUORESCENCE; OSTEOCYTES; RECEPTORS, CELL SURFACE;

EID: 84884373467     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Airas L., Niemela J., Salmi M., Puurunen T., Smith D.J. and Jalkanen S. (1997). Differential regulation and function of cd73, a glycosylphosphati dyl i nosi tol -l i nked 70-kd adhesi on mol ecul e, on lymphocytes and endothelial cells. J. Cell Biol. 136, 421-431.
2. Anderson D.A., Wu Y., Jiang S., Zhang X., Streeter P.R., Spangrude G.J., Archer D.R. and Fleming W.H. (2005). Donor marker infidelity in transgenic hematopoietic stem cells. Stem Cells 23, 638-643.
3. Appelbaum F.R. (2007). Hematopoietic-cell transplantation at 50. N. Engl. J. Med. 357, 1472-1475.
4. Araki H., Yoshinaga K., Boccuni P., Zhao Y., Hoffman R. and Mahmud N. (2007). Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. Blood 109, 3570-3578.
5. Barry F., Boynton R., Murphy M., Haynesworth S. and Zaia J. (2001). The sh-3 and sh-4 antibodies recognize distinct epitopes on cd73 from human mesenchymal stem cells. Biochem. Biophys. Res. Commun. 289, 519-524.
6. Billinton N. and Knight A.W. (2001). Seeing the wood through the trees: A review of techniques for distinguishing green fluorescent protein from endogenous autofluorescence. Anal. Biochem. 291, 175-197.
7. Boxall S.A. and Jones E. (2012). Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 2012, 975871.
8. Braun J., Kurtz A., Barutcu N., Bodo J., Thiel A. and Dong J. (2013). Concerted regul ati on of cd34 and cd105 accompani es mesenchymal stromal cell derivation from human adventitial stromal cell. Stem Cells Dev. 22, 815-827.
9. Brazelton T.R. and Blau H.M. (2005). Optimizing techniques for tracking transplanted stem cells in vivo. Stem Cells 23, 1251-1265.
10. Brulport M., Schormann W., Bauer A., Hermes M., Elsner C., Hammersen F.J., Beerheide W., Spitkovsky D., Hartig W., Nussler A., Horn L.C., Edelmann J., Pelz-Ackermann O., Petersen J., Kamprad M., von Mach M., Lupp A., Zulewski H. and Hengstler J.G. (2007). Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers. Hepatology 46, 861-870.
11. Caplan A.I. and Correa D. (2011). The msc: An injury drugstore. Cell Stem Cell 9, 11-15.
12. Castanheira P., Torquetti L.T., Magalhas D.R., Nehemy M.B. and Goes A.M. (2009). Dapi di ffusi on after i ntravi treal i nj ecti on of mesenchymal stem cells in the injured retina of rats. Cell Transplant. 18, 423-431.
13. Corselli M., Chen C.W., Sun B., Yap S., Rubin J.P. and Peault B. (2012). The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev. 21, 1299-1308.
14. Coyne T.M., Marcus A.J., Woodbury D. and Black I.B. (2006). Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 24, 2483-2492.
15. Craig W., Kay R., Cutler R.L. and Lansdorp P.M. (1993). Expression of thy-1 on human hematopoietic progenitor cells. J. Exp. Med. 177, 1331-1342.
16. da Silva Meirelles L., Chagastelles P.C. and Nardi N.B. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119, 2204-2213.
17. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D. and Horwitz E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8, 315-317.
18. Fina L., Molgaard H.V., Robertson D., Bradley N.J., Monaghan P., Delia D., Sutherland D.R., Baker M.A. and Greaves M.F. (1990). Expression of the cd34 gene in vascular endothelial cells. Blood 75, 2417-2426.
19. Gangenahalli G.U., Singh V.K., Verma Y.K., Gupta P., Sharma R.K., Chandra R. and Luthra P.M. (2006). Hematopoietic stem cell antigen cd34: Role in adhesion or homing. Stem Cells Dev. 15, 305-313.
20. Gimble J.M., Katz A.J. and Bunnell B.A. (2007). Adipose-derived stem cells for regenerative medicine. Circ. Res. 100, 1249-1260.
21. Gioglio L., Cusella de A.M., Boratto R. and Poggi P. (2002). An improved method for beta-galactosidase activity detection on muscle tissue. A light and electron microscopic study. Ann. Anat. 184, 153-157.
22. Hashikawa T., Takedachi M., Terakura M., Saho T., Yamada S., Thompson L.F., Shimabukuro Y. and Murakami S. (2003). Involvement of cd73 (ecto-5'-nucleotidase) in adenosine generation by human gingival fibroblasts. J. Dent. Res. 82, 888-892.
23. Haynesworth S.E., Baber M.A. and Caplan A.I. (1992). Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13, 69-80.
24. Iwashita Y., Crang A.J. and Blakemore W.F. (2000). Redistribution of bisbenzimide hoechst 33342 from transplanted cells to host cells. Neuroreport 11, 1013-1016.
25. Jurisic G., Iolyeva M., Proulx S.T., Halin C. and Detmar M. (2010). Thymus cell antigen 1 (thy1, cd90) is expressed by lymphatic vessels and mediates cell adhesion to lymphatic endothelium. Exp. Cell Res. 316, 2982-2992.
26. Kapuscinski J. (1995). Dapi: A DNA-specific fluorescent probe. Biotech. Histochem. 70, 220-233.
27. Kolf C.M., Cho E. and Tuan R.S. (2007). Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: Regulation of niche, selfrenewal and differentiation. Arthritis Res. Ther. 9, 204.
28. Kopp H.G., Hooper A.T., Shmelkov S.V. and Rafii S. (2007). Betagalactosidase staining on bone marrow. The osteoclast pitfall. Histol. Histopathol. 22, 971-976.
29. Kruyt M.C., De Bruijn J., Veenhof M., Oner F.C., Van Blitterswijk C.A., Verbout A.J. and Dhert W.J. (2003). Application and limitations of chloromethyl-benzamidodialkylcarbocyanine for tracing cells used in bone tissue engineering. Tissue Eng. 9, 105-115.
30. Lalu M.M., McIntyre L., Pugliese C., Fergusson D., Winston B.W., Marshall J.C., Granton J. and Stewart D.J. (2012). Safety of cell therapy with mesenchymal stromal cells (safecell): A systematic review and meta-analysis of clinical trials. PLoS One 7, e47559.
31. Li N., Yang H., Lu L., Duan C., Zhao C. and Zhao H. (2008). Comparison of the labeling efficiency of brdu, dii and fish labeling techniques in bone marrow stromal cells. Brain Res. 1215, 11-19.
32. Lin C.S. and Lue T.F. (2011). Adi pose-deri ved stem cells: Characterization and application in urology. In: Adipose stem cells and regenerative medicine, Illouz Y.G. and Sterodimas A. (eds). Springer. New York, NY. pp 193-207.
33. Lin C.S. and Lue T.F. (2013). Defining vascular stem cells. Stem Cells Dev. 22, 1018-1026.
34. Lin C.S., Ning H., Lin G. and Lue T.F. (2012a). Is cd34 truly a negative marker for mesenchymal stromal cells? Cytotherapy 14, 1159-1163.
35. Lin G., Garcia M., Ning H., Banie L., Guo Y.L., Lue T.F. and Lin C.S. (2008). Defining stem and progenitor cells within adipose tissue. Stem Cells Dev. 17, 1053-1063.
36. Lin G., Huang Y.C., Shindel A.W., Banie L., Wang G., Lue T.F. and Lin C.S. (2009). Labelling and tracking of mesenchymal stromal cells with edu. Cytotherapy 11, 864-873.
37. Lin G., Liu G., Banie L., Wang G., Ning H., Lue T.F. and Lin C.S. (2011). Tissue distribution of mesenchymal stem cell marker stro-1. Stem Cells Dev. 20, 1747-1752.
38. Lin G., Ning H., Banie L., Qiu X., Zhang H., Lue T.F. and Lin C.S. (2012b). Bone marrow cells stained by azide-conjugated alexa fluors in the absence of an alkyne label. Stem Cells Dev. 21, 2552-2559.
39. Lin G., Xin Z., Zhang H., Banie L., Wang G., Qiu X., Ning H., Lue T.F. and Lin C.S. (2012c). Identification of active and quiescent adipose vascular stromal cells. Cytotherapy 14, 240-246.
40. Maumus M., Peyrafitte J.A., D'Angelo R., Fournier-Wirth C., Bouloumie A., Casteilla L., Sengenes C. and Bourin P. (2011). Native human adipose stromal cells: Localization, morphology and phenotype. Int. J. Obes. 35, 1141-1153.
41. Mohorko N., Kregar-Velikonja N., Repovs G., Gorensek M. and Bresjanac M. (2005). An i n vi tro study of hoechst 33342 redistribution and its effects on cell viability. Hum. Exp. Toxicol. 24, 573-580.
42. Muller A.M., Hermanns M.I., Skrzynski C., Nesslinger M., Muller K.M. and Kirkpatrick C.J. (2002). Expression of the endothelial markers pecam-1, vwf, and cd34 in vivo and in vitro. Exp. Mol. Pathol. 72, 221-229.
43. Nassiri F., Cusimano M.D., Scheithauer B.W., Rotondo F., Fazio A., Yousef G.M., Syro L.V., Kovacs K. and Lloyd R.V. (2011). Endoglin (cd105): A review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res. 31, 2283-2290.
44. Nielsen J.S. and McNagny K.M. (2009). Cd34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation 16, 487-496.
45. Ning H., Lin G., Lue T.F. and Lin C.S. (2006). Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation 74, 510-518.
46. Ning H., Lin G., Lue T.F. and Lin C.S. (2011). Mesenchymal stem cell marker stro-1 is a 75 kd endothelial antigen. Biochem. Biophys. Res. Commun. 413, 353-357.
47. Ning H., Albersen M., Lin G., Lue T.F. and Lin C.S. (2013). Effects of edu labeling on mesenchymal stem cells. Cytotherapy 15, 57-63.
48. Onifer S.M., White L.A., Whittemore S.R. and Holets V.R. (1993). In vitro labeling strategies for identifying primary neural tissue and a neuronal cell line after transplantation in the cns. Cell Transplant. 2, 131-149.
49. Parish C.R. (1999). Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol. Cell Biol. 77, 499-508.
50. Pasquinelli G., Tazzari P.L., Vaselli C., Foroni L., Buzzi M., Storci G., Alviano F., Ricci F., Bonafe M., Orrico C., Bagnara G.P., Stella A. and Conte R. (2007). Thoracic aortas from multiorgan donors are suitable for obtaining resident angiogenic mesenchymal stromal cells. Stem Cells 25, 1627-1634.
51. Prockop D.J., Kota D.J., Bazhanov N. and Reger R.L. (2010). Evolving paradigms for repair of tissues by adult stem/progenitor cells (mscs). J. Cell Mol. Med. 14, 2190-2199.
52. Rakic P. (2002). Neurogenesis in adult primate neocortex: An evaluation of the evidence. Nat. Rev. Neurosci. 3, 65-71.
53. Rege T.A. and Hagood J.S. (2006). Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 20, 1045-1054.
54. Saalbach A., Wetzig T., Haustein U.F. and Anderegg U. (1999). Detection of human soluble thy-1 in serum by elisa. Fibroblasts and activated endothelial cells are a possible source of soluble thy-1 in serum. Cell Tissue Res. 298, 307-315.
55. Salic A. and Mitchison T.J. (2008). A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc. Natl. Acad. Sci. USA 105, 2415-2420.
56. Schormann W., Hammersen F.J., Brulport M., Hermes M., Bauer A., Rudolph C., Schug M., Lehmann T., Nussler A., Ungefroren H., Hutchinson J., Fandrich F., Petersen J., Wursthorn K., Burda M.R., Brustle O., Krishnamurthi K., von Mach M. and Hengstler J.G. (2008). Tracking of human cells in mice. Histochem. Cell Biol. 130, 329-338.
57. Simmons P.J. and Torok-Storb B. (1991). Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, stro-1. Blood 78, 55-62.
58. Spitzer N., Sammons G.S. and Price E.M. (2011). Autofluorescent cells in rat brain can be convincing impostors in green fluorescent reporter studies. J. Neurosci. Methods 197, 48-55.
59. Stolzing A., Bauer E. and Scutt A. (2012). Suspension cultures of bonemarrow-derived mesenchymal stem cells: Effects of donor age and glucose level. Stem Cells Dev. 21, 2718-2723.
60. Strohmeier G.R., Lencer W.I., Patapoff T.W., Thompson L.F., Carlson S.L., Moe S.J., Carnes D.K., Mrsny R.J. and Madara J.L. (1997). Surface expression, polarization, and functional significance of cd73 in human intestinal epithelia. J. Clin. Invest. 99, 2588-2601.
61. Swenson E.S., Price J.G., Brazelton T. and Krause D.S. (2007). Limitations of green fluorescent protein as a cell lineage marker. Stem Cells 25, 2593-2600.
62. Tamajusuku A.S., Carrillo-Sepulveda M.A., Braganhol E., Wink M.R., Sarkis J.J., Barreto-Chaves M.L. and Battastini A.M. (2006). Activity and expression of ecto-5'-nucleotidase/cd73 are increased by thyroid hormones in vascular smooth muscle cells. Mol. Cell. Biochem. 289, 65-72.
63. Torsney E., Mandal K., Halliday A., Jahangiri M. and Xu Q. (2007). Characterisation of progenitor cells in human atherosclerotic vessels. Atherosclerosis 191, 259-264.
64. Unger R.E., Krump-Konvalinkova V., Peters K. and Kirkpatrick C.J. (2002). In vi tro expressi on of the endothel i al phenotype: Comparative study of primary isolated cells and cell lines, including the novel cell line hpmec-st1.6r. Microvasc. Res. 64, 384-397.
65. Varma M.J., Breuls R.G., Schouten T.E., Jurgens W.J., Bontkes H.J., Schuurhuis G.J., van Ham S.M. and van Milligen F.J. (2007). Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cells Dev. 16, 91104.
66. Weiss D.J., Liggitt D. and Clark J.G. (1999). Hi stochemi cal discrimination of endogenous mammalian beta-galactosidase activity from that resulting from lac-z gene expression. Histochem. J. 31, 231-236.
67. Yoshimura K., Shigeura T., Matsumoto D., Sato T., Takaki Y., Aiba Kojima E., Sato K., Inoue K., Nagase T., Koshima I. and Gonda K. (2006). Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J. Cell. Physiol. 208, 64-76.
68. Zengin E., Chalajour F., Gehling U.M., Ito W.D., Treede H., Lauke H., Weil J., Reichenspurner H., Kilic N. and Ergun S. (2006). Vascular wall resident progenitor cells: A source for postnatal vasculogenesis. Development 133, 1543-1551.
69. Zimmerlin L., Donnenberg V.S., Pfeifer M.E., Meyer E.M., Peault B., Rubi n J.P. and Donnenberg A.D. (2010). Stromal vascul ar progenitors in adult human adipose tissue. Cytometry A 77, 22-30.
70. Zink D., Sadoni N. and Stelzer E. (2003). Visualizing chromatin and chromosomes in living cells. Methods 29, 42-50.